Immunomedics Stock

Immunomedics Stock Is Up 31.73% in 5 Weeks with More to Come

IMMU Stock: The Path of Least Resistance Is Geared Towards Higher Stock Prices On August 23, 2017, I focused on Immunomedics, Inc. (NASDAQ: IMMU) stock in a publication titled "Immunomedics Stock Has Its Sights Set on Higher Prices" when it was trading at $9.55. I am ecstatic to…

Immunomedics Stock Has Its Sights Set on Higher Prices

IMMU Stock: Bullish on Multiple Time Frames The focus of this publication is Immunomedics, Inc. (NASDAQ: IMMU) stock. This clinical stage biotechnology company develops treatments to boost the body's antibodies in order to fight serious diseases like cancer and autoimmune disorders. I have mentioned in a number of publications that…